Clinical trial
Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing…
NCT00135460 · Danish HIV Research Group, Other · Unknown status
Key facts
| NCT number | NCT00135460 |
|---|---|
| Title | Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients |
| Official title | Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in Patients With HIV. Influence on Morphological and Metabolic Disorders. A Randomized, Open-Label Multicenter Trial. |
| Lead sponsor | Danish HIV Research Group, Other |
| Collaborators | Rigshospitalet, Denmark Hvidovre University Hospital Odense University Hospital Aarhus University Hospital Aalborg University Hospital Abbott Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV-Associated Lipodystrophy Syndrome |
| Intervention type | Drug |
| Interventions | nucleoside analogue sparing HAART regimen |
| Enrollment | 100 |
| Start date | Jun 1, 2003 |
| Completion | Nov 1, 2007 |
| First posted | Aug 26, 2005 |
| Last update posted | Mar 14, 2006 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: